The Herald ghanaThe Herald ghana
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Reading: FDA boss runs from her negligence in GH¢94 million judgement debt case
Share
Aa
The Herald ghanaThe Herald ghana
Aa
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Search
  • Home
  • General
  • Entertainment
  • Politics
  • Editorial
  • Business
  • Sports
  • Feature
  • Health
  • World
Follow US
  • Advertise
Copyright © 2022 The Herald Ghana. All Rights Reserved
HealthMajor 1

FDA boss runs from her negligence in GH¢94 million judgement debt case

Published August 16, 2024 6 Min Read
Share
6 Min Read
SHARE

…Announces appeal

The Chief Executive of the Food and Drugs Authority (FDA), has denied being negligent in the defense of the case filed by Tobinco Pharmaceuticals Ltd, and expressed the Authority’s intention to appeal against the GH¢93,905,760.79 judgment debt imposed on it by an Accra High Court.

Dr Delese Darko, did not respond to the specific cases of the letters she wrote requesting for investigation of Tobinco, the various investigative reports on the fake, unregistered drugs, the various meetings, including one at the National Security Secretariat, the confessions of Samuel Amo Tobin, and the destruction and reshipment of the medicines, among others.

She equally did not mention in her statement issued yesterday, August 15, 2024, why she failed to enter the witness boss, although she claimed to have mounted a fight against Tobinco, saying “The action initiated against the FDA in 2019 has consistently and vigorously been responded to by the FDA”.

She rather tried hanging it on the neck of her former boss, Dr Stephen Kwabena Opuni, saying “Despite the claims made against the then CEO, Dr Stephen Opuni, by the applicant, Tobinco Pharmaceuticals Ltd, the current leadership of the organization, have provided a defence to the courts at all material times”.

More Read

Franko Herbal

FDA orders recall of Franko Herbal Mixture over diazepam, paracetamol contamination

FDA destroys 40ft container of unhygienic diapers imported from Spain
FDA uncovers syndicate selling fake Dr Alfred Capsules laced with sildenafil
Over 4 million fake, unregistered baby diapers seized nationwide

The court, on July 29, 2024, ordered the FDA to pay the said amount to Tobinco Pharmaceuticals Ltd. for the unlawful destruction of unexpired drugs belonging to the company.

In 2013, the FDA confiscated pharmaceutical products imported to Ghana by Tobinco because the products were unwholesome.

In 2019, Tobinco, sued the FDA six years after, asking the court to award costs against the Authourity and declare its action unlawful.

In reaching a decision, the court, presided over by Justice Audrey Kocuvie-Tay, declared that the wanton destruction of Tobinco’s unexpired products without obtaining any order from the court, was unlawful.

The court again declared that “the unlawful lockup of Tobinco’s warehouses by the FDA and bad media publicity by the FDA resulted in the massive expiration of Tobinco’s products between June 2014 and August 2015.”

Justice Kocuvie-Tay, further declared that the order by the FDA, prohibiting the sale of Tobinco’s products without obtaining an Executive Instrument (EI) from the Minister of Health, was unlawful.

She declared that the actions of the FDA and its CEO in banning Bliss GVS Pharma Limited from importing drugs into Ghana without the issuance of an E.I. by the minister, were unlawful.

The judge held that Tobinco, did not import fake drugs into the Ghanaian market.

However, the FDA, in a statement signed by its Chief Executive Officer, Dr Delese Darko, said it does not accept the court’s decision and will contest it at the Court of Appeal.

“The FDA acknowledges the judgment delivered by the High Court. However, the authority respectfully disagrees with the decision and intends to exercise its right to appeal. The FDA remains committed to upholding the judicial process and adhering to the rule of law and will follow due process until the matter is fully resolved.”

It further rubbished claims in the public space that its CEO was negligent in her actions, thus causing the Authority to suffer the loss.

“For the avoidance of doubt, the Authority informs the public that this case stems from actions taken in 2013. Despite the claims made against the then CEO, Dr. Stephen Opuni, by the applicant, Tobinco Pharmaceuticals Ltd., the current leadership of the organization has provided a defense to the courts at all material times. The action initiated against the FDA in 2019 has consistently and vigorously been responded to by the FDA,” the statement added.

Clarification on Tobinco Pharmaceuticals Ltd. v. Food and Drugs Authority

The Food and Drugs Authority (FDA) has noted with concern the manner in which the recent ruling in the case of Tobinco Pharmaceuticals Ltd. v. The Food and Drugs Authority is being reported in the media.

Some media reports suggest that the CEO, Dr Delese Darko, has been negligent in her actions, thus causing the Authority to suffer this loss.

For the avoidance of doubt, the Authority informs the public that this case stems from actions taken in 2013.

Despite the claims made against the then CEO, Dr Stephen Opuni, by the applicant, Tobinco Pharmaceuticals Ltd, the current leadership of the organisation have provided a defence to the courts at all material times.

The action initiated against the FDA in 2019 has consistently and vigorously been responded to by the FDA.

The FDA acknowledges the judgment delivered by the High Court. However, the Authority respectfully disagrees with the decision and intends to exercise its right to appeal.

The FDA remains committed to upholding the judicial process and adhering to the rule of law and will follow due process until the matter is fully resolved.

For all inquiries and concerns, please reach out to us through the contacts below.

Signed

Chief Executive Officer

Food and Drugs Authority

You Might Also Like

FDA orders recall of Franko Herbal Mixture over diazepam, paracetamol contamination

FDA destroys 40ft container of unhygienic diapers imported from Spain

FDA uncovers syndicate selling fake Dr Alfred Capsules laced with sildenafil

Over 4 million fake, unregistered baby diapers seized nationwide

razak.bawa August 16, 2024
Share this Article
Facebook Twitter Whatsapp Whatsapp Copy Link
What do you think?
Love0
Sad0
Cry0
Happy0
Surprise0
Angry0
Wink0
Previous Article Excitement builds for “This Is Ghana 2024” fair and exhibition
Next Article Critical documents expose Tobinco, FDA and Akufo-Addo’s law firm in GH¢94 million judgement debt saga

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe
- Advertisement -
Ad imageAd image

Latest News

court hammer/coup/marriage
Court of Appeal upholds life sentence for Jirapa Dubai hotel murder convict
General Major 4 November 19, 2026
Tottenham man arrested in Dublin over fatal stabbing of 21-year-old in North London
General Major 2 November 19, 2026
Emirates tops Time’s inaugural World’s Best Airlines 2027 rankings
Business Major 2 November 19, 2026
South Africa: Alex Dadey champions intergenerational African businesses, technology and regional partnerships at CNBC Africa Forum
Business Major 1 November 19, 2026
CurrencyRate

You Might also Like

Franko Herbal
GeneralMajor 3

FDA orders recall of Franko Herbal Mixture over diazepam, paracetamol contamination

October 20, 2026
GeneralMajor 2

FDA destroys 40ft container of unhygienic diapers imported from Spain

October 12, 2026
GeneralMajor 3

FDA uncovers syndicate selling fake Dr Alfred Capsules laced with sildenafil

September 9, 2026
GeneralMajor 3

Over 4 million fake, unregistered baby diapers seized nationwide

September 8, 2026
Show More

Copyright © 2022-2025 The Herald Ghana. All Rights Reserved

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?